Fundraising Fox
/Companies
Sign in

OWP Pharmaceuticals

Naperville, US · Illinois corporation

Find your way into OWP Pharmaceuticals

Each arrow is one introduction. Sign up to fill in the first one.

16 people can intro you to Scott

Ask Morgan Odell to introduce you to Scott Boyer

You →Morgan · together at Inventiv Health →Scott

14 people can intro you to STEVE

Ask Jamie Chen to introduce you to STEVE BOURNE

You →Jamie · together at Aksys, Ltd. →STEVE

Sign up to find every way you can get introduced to OWP Pharmaceuticals

  • Your email: who you already know at OWP Pharmaceuticals, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the OWP Pharmaceuticals team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

OWP Pharmaceuticals is a privately held, commercial-stage neuroscience specialty pharmaceutical company that develops and markets branded generic and generic lamotrigine Starter Kits (Subvenite) for epilepsy and bipolar disorder in the U.S. Operating as a social enterprise, it donates profits to the ROW Foundation to support treatment of neurological disorders in under-resourced regions.

BiotechHealthtechImpact & Social Good

Founders & leadership

SBScott Boyer
Scott BoyerFounder and PresidentScott Boyer is Founder and President of OWP Pharmaceuticals, a specialty pharmaceutical company that commercializes neuroscience products in the U.S., and founded the associated ROW Foundation, which provides educational, diagnostic, and treatment resources for neurological disorders in under-resourced regions globally.
SBSTEVE BOURNE
STEVE BOURNEChief Financial OfficerSteve Bourne is an executive officer at OWP Pharmaceuticals with over 25 years of experience in finance, administration, and operations roles at specialty pharmaceutical, life science, and medical device companies. He has led scaling efforts and financial management at both pre-commercial and post-launch stages.

Board

CG
CAROL GAVINBoard director
KF
KURT FLORIANBoard director
PR
PAUL REGANBoard director
TH
TROY HAMMONDBoard director
BD
BRUCE DUNCANBoard director

Reported raises · per SEC filings

Form D private placements

$5.1M disclosed across 2 rounds · 2024–2025

▶$2.4MraisedSep 2025 · 19 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • TROY HAMMONDDirector
  • STEVE BOURNEExecutive Officer
  • MATT LITFINDirector
  • KURT FLORIANDirector
  • SCOTT BOYERExecutive Officer, Director
  • BRUCE DUNCANDirector
Offering amount
$2.4M
Amount sold
$2.4M
Minimum investment
$25K
First sale
Jul 2025
Incorporated
Corporation, Illinois
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2.7MraisedSep 2024 · 11 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • STEVE BOURNEExecutive Officer
  • CAROL GAVINDirector
  • SCOTT BOYERExecutive Officer, Director
  • KURT FLORIANDirector
  • PAUL REGANDirector
  • TROY HAMMONDDirector
  • BRUCE DUNCANDirector
Offering amount
$2.7M
Amount sold
$2.7M
Minimum investment
$25K
First sale
Jun 2024
Incorporated
Corporation, Illinois
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

WalgreensWalgreens operates a pharmacy and retail health and wellness business, offering prescription services, over-the-counter medications, health products, and photo services to consumers.
BionpharmaBionpharma researches, develops, and manufactures generic prescription drugs and over-the-counter products, and is one of the largest US suppliers of softgel capsules. It also sells OTC products online through its A+ Health brand on Amazon.

Companies working in the same space as OWP Pharmaceuticals.

In the news

FAQs | OWP Pharmaceuticalsowppharma.com · Apr 2021

Frequently asked questions

What does OWP Pharmaceuticals do?
OWP Pharmaceuticals is a privately held, commercial-stage neuroscience specialty pharmaceutical company that develops and markets branded generic and generic lamotrigine Starter Kits (Subvenite) for epilepsy and bipolar disorder in the U.S. Operating as a social enterprise, it donates profits to the ROW Foundation to support treatment of neurological disorders in under-resourced regions.
Who founded OWP Pharmaceuticals?
OWP Pharmaceuticals was founded by Scott Boyer.
How much funding has OWP Pharmaceuticals raised?
OWP Pharmaceuticals has disclosed $5.1M raised across 2 rounds.
Where is OWP Pharmaceuticals headquartered?
OWP Pharmaceuticals is headquartered in Naperville, US.